Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1978 Sep;14(3):495–497. doi: 10.1128/aac.14.3.495

Inosiplex for Localized Herpes Zoster in Childhood Cancer Patients: Preliminary Controlled Study

S Feldman 1, F A Hayes 1, S Chaudhary 1, M Ossi 1
PMCID: PMC352489  PMID: 81655

Abstract

By multiple criteria, inosiplex—a reputed stimulator of virus-sensitized lymphocytes—had no demonstrable therapeutic effects in a preliminary controlled study of patients with localized herpes zoster and cancer. Lymphocytes from the six drug-treated patients were no more responsive to varicella-zoster antigen and phytohemagglutinin than were lymphocytes from seven patients who received a placebo.

Full text

PDF
495

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blanden R. V. Mechanisms of recovery from a generalized viral infection: mousepox. 3. Regression infectious foci. J Exp Med. 1971 May 1;133(5):1090–1104. doi: 10.1084/jem.133.5.1090. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Blanden R. V. Mechanisms of recovery from a generalized viral infection: mousepox. I. The effects of anti-thymocyte serum. J Exp Med. 1970 Nov;132(5):1035–1054. doi: 10.1084/jem.132.5.1035. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blanden R. V. Mechanisms of recovery from a generalized viral infection: mousepox. II. Passive transfer of recovery mechanisms with immune lymphoid cells. J Exp Med. 1971 May 1;133(5):1074–1089. doi: 10.1084/jem.133.5.1074. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bradshaw L. J., Sumner H. L. In vitro studies on cell-mediated immunity in patients treated with inosiplex for herpes virus infection. Ann N Y Acad Sci. 1977 Mar 4;284:190–196. doi: 10.1111/j.1749-6632.1977.tb21950.x. [DOI] [PubMed] [Google Scholar]
  5. Dent P. B., Larke R. P. Viral infection and immunity. Med Clin North Am. 1972 Mar;56(2):353–370. doi: 10.1016/s0025-7125(16)32401-4. [DOI] [PubMed] [Google Scholar]
  6. Feldman S., Chaudary S., Ossi M., Epp E. A viremic phase for herpes zoster in children with cancer. J Pediatr. 1977 Oct;91(4):597–600. doi: 10.1016/s0022-3476(77)80509-x. [DOI] [PubMed] [Google Scholar]
  7. Feldman S., Hughes W. T., Darlington R. W., Kim H. K. Evaluation of topical polyinosinic acid-polycytidylic acid in treatment of localized herpes zoster in children with cancer: a randomized, double-blind controlled study. Antimicrob Agents Chemother. 1975 Sep;8(3):289–294. doi: 10.1128/aac.8.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ginsberg T., Glasky A. J. Inosiplex: an immunomodulation model for the treatment of viral disease. Ann N Y Acad Sci. 1977 Mar 4;284:128–138. doi: 10.1111/j.1749-6632.1977.tb21944.x. [DOI] [PubMed] [Google Scholar]
  9. Glasgow L. A. Cellular immunity in host resistance to viral infections. Arch Intern Med. 1970 Jul;126(1):125–134. [PubMed] [Google Scholar]
  10. Gordon P., Ronsen B., Brown E. R. Anti-herpesvirus action of isoprinosine. Antimicrob Agents Chemother. 1974 Feb;5(2):153–160. doi: 10.1128/aac.5.2.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hadden J. W., Hadden E. M., Coffey R. G. Isoprinosine augmentation of phytohemagglutinin-induced lymphocyte proliferation. Infect Immun. 1976 Feb;13(2):382–387. doi: 10.1128/iai.13.2.382-387.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Longley S., Dunning R. L., Waldman R. H. Effect of isoprinosine against challenge with A(H3N2)-Hong Kong influenza virus in volunteers. Antimicrob Agents Chemother. 1973 Apr;3(4):506–509. doi: 10.1128/aac.3.4.506. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Waldman R. H., Ganguly R. Therapeutic efficacy of inosiplex (Isoprinosine) in rhinovirus infection. Ann N Y Acad Sci. 1977 Mar 4;284:153–160. doi: 10.1111/j.1749-6632.1977.tb21946.x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES